Tara Arvedson

5.0k total citations · 1 hit paper
30 papers, 1.6k citations indexed

About

Tara Arvedson is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Tara Arvedson has authored 30 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 12 papers in Genetics and 11 papers in Oncology. Recurrent topics in Tara Arvedson's work include Iron Metabolism and Disorders (11 papers), CAR-T cell therapy research (10 papers) and Hemoglobinopathies and Related Disorders (10 papers). Tara Arvedson is often cited by papers focused on Iron Metabolism and Disorders (11 papers), CAR-T cell therapy research (10 papers) and Hemoglobinopathies and Related Disorders (10 papers). Tara Arvedson collaborates with scholars based in United States, Germany and Austria. Tara Arvedson's co-authors include Barbra J. Sasu, Graham Molineux, Keegan S. Cooke, Les P. Miranda, Aaron Winters, Alexander S. Powers, Shane Gonen, Ron O. Dror, Yifan Cheng and Caleigh M. Azumaya and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Tara Arvedson

29 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms

2020 242 citations Christian B. Billesbølle, Caleigh M. Azumaya et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tara Arvedson United States	20	811	497	482	358	336	30	1.6k
Ruoping Tang France	24	340 0.4×	386 0.8×	675 1.4×	729 2.0×	32 0.1×	40	1.7k
Gaurav S. Choudhary United States	17	252 0.3×	333 0.7×	1.0k 2.1×	450 1.3×	51 0.2×	35	1.7k
Shalini Verma United States	11	421 0.5×	210 0.4×	553 1.1×	227 0.6×	34 0.1×	15	1.2k
Ietje Kathmann Netherlands	23	206 0.3×	81 0.2×	649 1.3×	550 1.5×	139 0.4×	40	1.4k
György Várady Hungary	23	124 0.2×	135 0.3×	804 1.7×	989 2.8×	155 0.5×	73	1.7k
Jimmy D. Page United States	14	329 0.4×	308 0.6×	310 0.6×	151 0.4×	82 0.2×	20	981
Eric B. Springman United States	15	234 0.3×	142 0.3×	479 1.0×	348 1.0×	53 0.2×	25	1.1k
HJ Broxterman Netherlands	19	276 0.3×	138 0.3×	1.1k 2.3×	1.9k 5.4×	139 0.4×	27	2.5k
Randall M. Rossi United States	17	1.0k 1.2×	214 0.4×	1.8k 3.8×	678 1.9×	41 0.1×	36	2.9k
Marie‐Françoise Bourgeade France	23	231 0.3×	116 0.2×	722 1.5×	379 1.1×	52 0.2×	46	1.5k

Countries citing papers authored by Tara Arvedson

Since Specialization

Citations

This map shows the geographic impact of Tara Arvedson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tara Arvedson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tara Arvedson more than expected).

Fields of papers citing papers by Tara Arvedson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tara Arvedson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tara Arvedson. The network helps show where Tara Arvedson may publish in the future.

Co-authorship network of co-authors of Tara Arvedson

This figure shows the co-authorship network connecting the top 25 collaborators of Tara Arvedson. A scholar is included among the top collaborators of Tara Arvedson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tara Arvedson. Tara Arvedson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rohrbacher, Lisa, Daniel Nixdorf, Bettina Brauchle, et al.. (2025). FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion. Blood Advances. 10(4). 1179–1193.

Arvedson, Tara, Julie M. Bailis, Thomas Urbig, & Jennitte Stevens. (2022). Considerations for design, manufacture, and delivery for effective and safe T-cell engager therapies. Current Opinion in Biotechnology. 78. 102799–102799. 23 indexed citations

Goldstein, Rebecca, Anja Henn, Petra Deegen, et al.. (2022). Abstract 6313: Evaluation of a dual CD123-FLT3 BiTE molecule for acute myeloid leukemia. Cancer Research. 82(12_Supplement). 6313–6313. 1 indexed citations

Kopecky, David J., Laurie P. Volak, Michael D. Bartberger, et al.. (2020). Systematic Study of the Glutathione Reactivity of N -Phenylacrylamides: 2. Effects of Acrylamide Substitution. Journal of Medicinal Chemistry. 63(20). 11602–11614. 44 indexed citations

Goldstein, Rebecca, Ana Goyos, Chi-Ming Li, et al.. (2020). AMG 701 induces cytotoxicity of multiple myeloma cells and depletes plasma cells in cynomolgus monkeys. Blood Advances. 4(17). 4180–4194. 37 indexed citations

Billesbølle, Christian B., Caleigh M. Azumaya, Rachael C. Kretsch, et al.. (2020). Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms. Nature. 586(7831). 807–811. 242 indexed citations breakdown →

Haschka, David, Verena Petzer, Florian Kocher, et al.. (2019). Classical and intermediate monocytes scavenge non-transferrin-bound iron and damaged erythrocytes. JCI Insight. 4(8). 23 indexed citations

Ross, Sandra L., Marika Sherman, Patricia McElroy, et al.. (2017). Bispecific T cell engager (BiTE®) antibody constructs can mediate bystander tumor cell killing. PLoS ONE. 12(8). e0183390–e0183390. 80 indexed citations

Ross, Sandra L., Kaustav Biswas, James B. Rottman, et al.. (2017). Identification of Antibody and Small Molecule Antagonists of Ferroportin-Hepcidin Interaction. Frontiers in Pharmacology. 8. 838–838. 25 indexed citations

10.

Arvedson, Tara, Mercedesz Balázs, Kurt A. Black, et al.. (2017). Abstract 55: Generation of half-life extended anti-CD33 BiTE® antibody constructs compatible with once-weekly dosing. Cancer Research. 77(13_Supplement). 55–55. 23 indexed citations

11.

Tesfay, Lia, Jin Woo Kim, Poornima Hegde, et al.. (2015). Hepcidin Regulation in Prostate and Its Disruption in Prostate Cancer. Cancer Research. 75(11). 2254–2263. 139 indexed citations

12.

Arvedson, Tara, James O’Kelly, & Bingbing Yang. (2015). Design Rationale and Development Approach for Pegfilgrastim as a Long-Acting Granulocyte Colony-Stimulating Factor. BioDrugs. 29(3). 185–198. 55 indexed citations

13.

Campuzano, Iain D. G., et al.. (2015). High-Throughput Mass Spectrometric Analysis of Covalent Protein-Inhibitor Adducts for the Discovery of Irreversible Inhibitors: A Complete Workflow. SLAS DISCOVERY. 21(2). 136–144. 46 indexed citations

14.

Cee, Victor J., Laurie P. Volak, Yuping Chen, et al.. (2015). Systematic Study of the Glutathione (GSH) Reactivity ofN-Arylacrylamides: 1. Effects of Aryl Substitution. Journal of Medicinal Chemistry. 58(23). 9171–9178. 110 indexed citations

15.

Smith, C., Tara Arvedson, Keegan S. Cooke, et al.. (2013). IL-22 Regulates Iron Availability In Vivo through the Induction of Hepcidin. The Journal of Immunology. 191(4). 1845–1855. 52 indexed citations

16.

Ross, Sandra L., Lynn Tran, Aaron Winters, et al.. (2012). Molecular Mechanism of Hepcidin-Mediated Ferroportin Internalization Requires Ferroportin Lysines, Not Tyrosines or JAK-STAT. Cell Metabolism. 15(6). 905–917. 116 indexed citations

17.

Arvedson, Tara, Lynn Tran, Sandra L. Ross, et al.. (2012). Fetal Hemoglobin Expression Is Differentially Affected by Inhibition of the Proposed Dred Complex Constituents, LSD1 and DNMT1. Blood. 120(21). 3263–3263. 1 indexed citations

18.

Sasu, Barbra J., Hongyan Li, Mark J. Rose, et al.. (2010). Serum hepcidin but not prohepcidin may be an effective marker for anemia of inflammation (AI). Blood Cells Molecules and Diseases. 45(3). 238–245. 33 indexed citations

19.

Zhang, Jingwen, et al.. (2010). Oxidative folding of hepcidin at acidic pH. Biopolymers. 94(2). 257–264. 27 indexed citations

20.

Sasu, Barbra J., Keegan S. Cooke, Tara Arvedson, et al.. (2010). Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia. Blood. 115(17). 3616–3624. 188 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact